Source: Frank M. Balis Concentration and Effect vs. Time Conc./ Amount Effect [% of E MAX ] Time Central Compartment Peripheral Compartment Effect Compartment.

Slides:



Advertisements
Similar presentations
Karunya Kandimalla, Ph.D
Advertisements

PHARMACOKINETIC MODELS
First, zero, pseudo-zero order elimination Clearance
Clinical Pharmacokinetics
PHARMACOKINETIC.
DISPOSITION OF DRUGS The disposition of chemicals entering the body (from C.D. Klaassen, Casarett and Doull’s Toxicology, 5th ed., New York: McGraw-Hill,
SEMINAR ON NONCOMPARTMENTAL PHARMACOKINETICS
Non compartmental analysis
Mathematic descript. of A) Biolog. processes affecting drugs B) Biolog. processes affected by drugs drugs Pharmacokinetics Mathematical expressions to.
Pharmacokinetics & Pharmacodynamics
Pharmacokinetics -- part 1 --
Selected bioavailability and pharmacokinetic calculations Dr. Osama A. A. Ahmed.
Pharmacokinetics of Drug Absorption
Nonlinear pharmacokinetics
Two-compartment model
One-compartment open model: Intravenous bolus administration
Practical Pharmacokinetics
Practical Pharmacokinetics September 11, 2007 Frank F. Vincenzi.
Week 4 - Biopharmaceutics and Pharmacokinetics
Pharmacokinetics Based on the hypothesis that the action of a drug requires presence of a certain concentration in the fluid bathing the target tissue.
Toxicokinetic Calculations
Gokaraju Rangaraju College of Pharmacy
Karunya Kandimalla, Ph.D. Assistant Professor, Pharmaceutics
University of Jordan-Faculty of Pharmacy
The General Concepts of Pharmacokinetics and Pharmacodynamics Hartmut Derendorf, PhD University of Florida.
PHARMACOKINETICS 1. Fate of drugs in the body 1.1 absorption
PK/PD Modeling in Support of Drug Development Alan Hartford, Ph.D. Associate Director Scientific Staff Clinical Pharmacology Statistics Merck Research.
Nonlinear Pharmacokinetics
Nonlinear Pharmacokinetics Prepared By, Jahanvi H. Patel Roll No:09MPH103 Dept: Pharmaceutical Technology & Biopharmaceutics Guided By: Dhaivat C. Parikh.
Pharmacokinetics Introduction
Non-linear Pharmacokinetics Arthur G. Roberts. Linear Pharmacokinetics AUC dose K Cl dose [Drug] plasma time ln[Drug] plasma time Increasing Dose.
Bioavailability Dr Mohammad Issa.
BASIC PHARMACOKINETIC PARAMETERS. PHARMACOKINETICS Pharmacokinetics is the study of the time course of a drug within the body and incorporates the processes.
PHARMACOKINETIC MODELS
Introduction to PK/PD Modeling for Statisticians Part 1
1-Compartment Oral Dosing 400 mg of moxifloxacin is administered orally to Mr BB, a 68 yr old male who weighs 75 kg. Blood samples were drawn following.
Area under the plasma concentration time curve. IMPORTANCE OF AUC Pharmacokinetics - measurement of bioavaibility absolute, relative Biopharmaceutics.
MECHANISTIC PHARMACOKINETICS: COMPARTMENTAL MODELS
Drug Administration Pharmacokinetic Phase (Time course of ADME processes) Absorption Distribution Pharmaceutical Phase Disintegration of the Dosage Form.
The General Concepts of Pharmacokinetics and Pharmacodynamics
1 Single-dose kinetics Plasma [Drug] curve Upon administration [drug] plasma reaches a max Then begins to decline as the Drug is eliminated Cp max = max.
Noncompartmental Models. Introduction The noncompartmental approach for data analysis does not require any specific compartmental model for the system.
1. Fate of drugs in the body 1.1 absorption 1.2 distribution - volume of distribution 1.3 elimination - clearance 2. The half-life and its uses 3. Repeated.
INTRODUCTION CLINICAL PHARMACOKINETICS
BIOPHARMACEUTICS.
Principles of pharmacokinetics Prof. Kršiak Department of Pharmacology, Third Faculty of Medicine, Charles University in Prague Cycle II, Subject: General.
MS Phoenix WinNonLin Project
Nonlinear Pharmacokinetics
Study Aids Anki Flash cards – Content that you need to know for the tests. MS Excel sheet with Calculations.
DEFINITIONS T1/2 & Tmax Cmax AUC 1st order kinetics
The General Concepts of Pharmacokinetics and Pharmacodynamics
415 PHT Plasma Level – Time Curve
Learning objectives To know what data is available from pharmacokinetic studies in man and how to handle it To know how to calculate the basic pharmacokinetic.
Pharmacokinetics (PK) and Pharmacodynamics (PD) of Rivaroxaban: A Comparison of Once- and Twice-daily Dosing in Patients Undergoing Total Hip Replacement.
INTRODUCTION TO PHARMACOKINETICS M. Kršiak Department of Pharmacology, Third Faculty of Medicine, Charles University in Prague, Charles University in Prague,
MULTIPLE DOSAGE REGIMEN
MS WinNonLin Project 9/28/15: PK Modeling I project due today.
Drug Response Relationships
Physiology for Engineers
Chapter 8 BIOAVAILABILITY & BIOEQUIVALENCE
Applications of Pharmacokinetics
Lab-3 practical pharmacology
Quantitative Pharmacokinetics
Selected Bioavailability and Pharmacokinetic Calculations
1 Concentration-time curve
Therapeutic Drug Monitoring chapter 1 part 1
Plasma concentration–time profile, relative bioavailability and pharmacokinetic (PK) parameters of 4 mg TAK-228 in the single-agent QD PK run-in period,
Plasma concentration-time profile after oral administration of a single dose. Plasma concentration-time profile after oral administration of a single dose.
Presentation transcript:

source: Frank M. Balis Concentration and Effect vs. Time Conc./ Amount Effect [% of E MAX ] Time Central Compartment Peripheral Compartment Effect Compartment Effect Non-Steady State

Pharmacokinetics (PK) 2 Quantitative analysis of the kinetics (time course) and steady state (SS) relationships of drug “What the body does to the drug” ADME –Absorption –Distribution –Metabolism –Excretion Elimination

Pharmacokinetic concepts

4 Important PK parameters AUC: area under the concentration-time curve  measure of the extent of absorption Cmax: the observed maximum concentration of a drug  measure of the rate of absorption C max T max AUC tmax: time at which Cmax is observed  measure of the rate of absorption

Bioavailability 5

Steady State

Steady State vs. Kinetic Studies Many PK/PD concepts are for SS –Clearance; Volume of distribution –SS PD effect for given SS concentration (time to PD SS may be longer than time to plasma SS) But some studies are kinetic –e.g., single oral dose or I.V. bolus –Tracer kinetic studies; PET –Aim may be infer SS under repeated dosing

Linear vs Non-linear System “Linear Pharmacokinetics” –double the dose  concentration doubles AUC proportional to dose AUC proportional to dose –Superposition principle (example): If {I.V. bolus}  C iv (t) and {oral dose}  C oral (t), then {both dosing together}  then {both dosing together}  C(t)  C iv (t) + C oral (t) C(t)  C iv (t) + C oral (t) –holds for small enough doses (microdoses) –linearity for large doses if transport, binding, and elimination remain first order